opc 12759 has been researched along with Atherogenesis in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jhun, J | 1 |
| Kwon, JE | 1 |
| Kim, SY | 1 |
| Jeong, JH | 1 |
| Na, HS | 1 |
| Kim, EK | 1 |
| Lee, SH | 1 |
| Jung, K | 1 |
| Min, JK | 1 |
| Cho, ML | 1 |
1 other study available for opc 12759 and Atherogenesis
| Article | Year |
|---|---|
Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.
Topics: Alanine; Animals; Antioxidants; Aorta; Apolipoproteins E; Arthritis; Atherosclerosis; Collagen; Foam | 2017 |